Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Sep;4(7):E1-5.
doi: 10.1002/jhm.445.

Trends in catheter ablation for atrial fibrillation in the United States

Patrick P Kneeland  1 , Margaret C Fang
Affiliations

Trends in catheter ablation for atrial fibrillation in the United States

Patrick P Kneeland et al. J Hosp Med. 2009 Sep.

Abstract

Background: There are few data on the use of catheter ablation for atrial fibrillation (AF) in the United States. We analyzed data from the National Hospital Discharge Survey (NHDS) to examine trends in the rate of catheter ablation for hospitalized patients with AF over a 15-year period.

Objective: To examine rates of catheter ablation in patients with AF over time.

Design: All adult patients in the NHDS with an International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) code for AF from the years 1990 to 2005 were identified and assessed for the presence of a cardiac catheter ablation procedure code. Clinical characteristics associated with ablation were identified and multivariable logistic regression used to determine trends in the rate of ablation therapy over time.

Results: We identified 269,471 adults with AF. The rate of catheter ablation in AF patients increased from 0.06% in 1990 to 0.79% in 2005 (P < 0.001 for trend). Compared to those not undergoing ablation, ablated patients were younger (mean age 66 versus 76 years; P < 0.001), more likely to be male (57% versus 43%; P < 0.001), have private insurance (22% versus 11%; P < 0.001), and have a none of the following stroke risk factors: congestive heart failure, hypertension, age >75 years, diabetes mellitus, or stroke/transient ischemic attack (37% versus 16%; P < 0.001). Catheter ablation in AF patients increased by 15% per year over the time period (95% confidence interval [CI], 13%-16%) and across all age groups, including in patients age > or =80 years (0.0% in 1990 and 0.26% in 2005; P < 0.001 for trend).

Conclusions: The rate of catheter ablation in patients with AF is increasing significantly over time, even in the oldest patients. Medicine.

PubMed Disclaimer

Conflict of interest statement

Neither of the authors have conflicts of interest pertaining to the manuscript.

Figures

Figure 1
Figure 1
Overall Rate of Catheter Ablation Procedures in 269,471 Hospitalizations of Patients With Atrial Fibrillation From Years 1990 to 2005.
Figure 2
Figure 2
The Rate of Catheter Ablation Procedures in 269,471 Hospitalizations of Patients With Atrial Fibrillation From Years 1990 to 2005, stratified By Patient Age.
See this image and copyright information in PMC

References

    1. Go AS, Hylek EM, Phillips KA, Chang Y, et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA. 2001;285(18):2370–2375. - PubMed
    1. Atrial Fibrillation Investigators. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials. Arch Intern Med. 1994;154(13):1449–1457. - PubMed
    1. Stewart S, Hart CL, Hole DJ, McMurray JJ. A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study. Am J Med. 2002;113(5):359–364. - PubMed
    1. Krahn AD, Manfreda J, Tate RB, Mathewson FA, Cuddy TE. The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study. Am J Med. 1995;98(5):476–484. - PubMed
    1. Poole-Wilson PA, Swedberg K, Cleland JG, et al. Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomized controlled trial. Lancet. 2003;362(9377):7–13. - PubMed

Publication types